Therapy of human solid tumor xenografts with CD74-targeted milatuzumab-SN-38 immunoconjugates.
David M. Goldenberg
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics
Thomas M. Cardillo
Employment or Leadership Position - Immunomedics
Robert M. Sharkey
No relevant relationships to disclose
David V. Gold
No relevant relationships to disclose
Serengulam V. Govindan
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics (B)